It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INDV’s FA Score shows that 0 FA rating(s) are green whileMILFF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INDV’s TA Score shows that 3 TA indicator(s) are bullish while MILFF’s TA Score has 2 bullish TA indicator(s).
INDV (@Pharmaceuticals: Generic) experienced а +6.64% price change this week, while MILFF (@Pharmaceuticals: Generic) price change was -17.68% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.
INDV is expected to report earnings on Oct 23, 2025.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
INDV | MILFF | INDV / MILFF | |
Capitalization | 2.93B | 23.1M | 12,671% |
EBITDA | 261M | 4.15M | 6,297% |
Gain YTD | 88.737 | -11.567 | -767% |
P/E Ratio | 28.96 | 11.52 | 251% |
Revenue | 1.17B | 70.3M | 1,669% |
Total Cash | 510M | 5.86M | 8,700% |
Total Debt | 366M | 7.57M | 4,836% |
INDV | MILFF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 45 | 100 | |
SMR RATING 1..100 | 77 | 81 | |
PRICE GROWTH RATING 1..100 | 35 | 47 | |
P/E GROWTH RATING 1..100 | 100 | 96 | |
SEASONALITY SCORE 1..100 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MILFF's Valuation (56) in the null industry is somewhat better than the same rating for INDV (94). This means that MILFF’s stock grew somewhat faster than INDV’s over the last 12 months.
INDV's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for MILFF (100). This means that INDV’s stock grew somewhat faster than MILFF’s over the last 12 months.
INDV's SMR Rating (77) in the null industry is in the same range as MILFF (81). This means that INDV’s stock grew similarly to MILFF’s over the last 12 months.
INDV's Price Growth Rating (35) in the null industry is in the same range as MILFF (47). This means that INDV’s stock grew similarly to MILFF’s over the last 12 months.
MILFF's P/E Growth Rating (96) in the null industry is in the same range as INDV (100). This means that MILFF’s stock grew similarly to INDV’s over the last 12 months.
INDV | MILFF | |
---|---|---|
RSI ODDS (%) | 3 days ago66% | 3 days ago61% |
Stochastic ODDS (%) | 3 days ago64% | 3 days ago60% |
Momentum ODDS (%) | N/A | 3 days ago70% |
MACD ODDS (%) | 3 days ago70% | 3 days ago67% |
TrendWeek ODDS (%) | 3 days ago76% | 3 days ago67% |
TrendMonth ODDS (%) | 3 days ago77% | 3 days ago68% |
Advances ODDS (%) | 3 days ago72% | N/A |
Declines ODDS (%) | 28 days ago74% | N/A |
BollingerBands ODDS (%) | 3 days ago66% | 3 days ago74% |
Aroon ODDS (%) | 3 days ago82% | 3 days ago75% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIQEX | 75.70 | 0.08 | +0.11% |
Fidelity Advisor Canada Z | |||
USPFX | 33.43 | 0.01 | +0.03% |
Union Street Partners Value Advisor | |||
FFBGX | 40.45 | -0.01 | -0.02% |
American Funds Global Balanced 529-F-3 | |||
JVTIX | 86.81 | -0.06 | -0.07% |
Janus Henderson Venture I | |||
ARSMX | 9.85 | -0.07 | -0.71% |
AMG River Road Small-Mid Cap Value N |
A.I.dvisor tells us that INDV and ALKS have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and ALKS's prices will move in lockstep.
Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
---|---|---|---|---|
INDV | 100% | +1.25% | ||
ALKS - INDV | 25% Poorly correlated | +2.80% | ||
HROW - INDV | 24% Poorly correlated | -2.97% | ||
VTRS - INDV | 23% Poorly correlated | -0.75% | ||
COLL - INDV | 23% Poorly correlated | +1.56% | ||
AMRX - INDV | 23% Poorly correlated | +0.64% | ||
More |
A.I.dvisor tells us that MILFF and JUSHF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MILFF and JUSHF's prices will move in lockstep.
Ticker / NAME | Correlation To MILFF | 1D Price Change % | ||
---|---|---|---|---|
MILFF | 100% | -18.33% | ||
JUSHF - MILFF | 5% Poorly correlated | -10.65% | ||
IPSEY - MILFF | 5% Poorly correlated | N/A | ||
KSPHF - MILFF | 3% Poorly correlated | N/A | ||
MGWFF - MILFF | 1% Poorly correlated | -34.87% | ||
INDV - MILFF | 1% Poorly correlated | +1.25% | ||
More |